Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 36,566 | 67,330 | 29,568 | 83,079 | 57,608 |
| Depreciation Amortization | 23,738 | 15,170 | 6,600 | 1,239 | 624 |
| Income taxes - deferred | -18,701 | -4,758 | -1,519 | 4,937 | 3,652 |
| Accounts receivable | -37,610 | -32,357 | -22,963 | -3,820 | -2,718 |
| Accounts payable and accrued liabilities | 623 | 446 | -584 | 1,207 | -239 |
| Other Working Capital | -44,978 | -41,367 | -25,665 | 13,729 | 3,012 |
| Other Operating Activity | 128,314 | 38,360 | 26,633 | 15,676 | 14,031 |
| Operating Cash Flow | $87,952 | $42,824 | $12,070 | $116,047 | $75,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -138 | -74 | -74 | -29 | -29 |
| Purchase Of Investment | -13,465 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 19,238 | 19,238 |
| Other Investing Activity | -241,581 | -162,293 | -162,293 | -10,000 | -10,000 |
| Investing Cash Flow | $-255,184 | $-162,367 | $-162,367 | $9,209 | $9,209 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,099 | 1,887 | 1,270 | 9,569 | 6,368 |
| Common Stock Repurchased | N/A | N/A | N/A | -6,907 | -6,907 |
| Other Financing Activity | -12,291 | -1,952 | -1,121 | -968 | -20 |
| Financing Cash Flow | $-10,192 | $-65 | $149 | $1,694 | $-559 |
| Beginning Cash Position | 298,395 | 298,395 | 298,395 | 171,445 | 171,445 |
| End Cash Position | 120,971 | 178,787 | 148,247 | 298,395 | 256,065 |
| Net Cash Flow | $-177,424 | $-119,608 | $-150,148 | $126,950 | $84,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | 87,952 | 42,824 | 12,070 | 116,047 | 75,970 |
| Capital Expenditure | -138 | -74 | -74 | -29 | -29 |
| Free Cash Flow | 87,814 | 42,750 | 11,996 | 116,018 | 75,941 |